AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04502576 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Noninvasive respiratory support
Description: In both arms, the treatment according to the assigned protocol will be continued until the patient requires endotracheal intubation or (in case of no intubation) up to ICU discharge.~Patients will have to undergo the allocated treatment within 1 hour from the moment of randomization and within 24 hours from admission in the intensive care unit
Study NCT02469948 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: To inject Botulinum toxin type A on the spasticity lower extremity for stroke patients by Ultrasonography direct-guidance, Electric stimulation and Surface anatomy landmark.
Study NCT02469948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: To inject Botulinum toxin type A on the spasticity lower extremity for stroke patients by Ultrasonography direct-guidance, Electric stimulation and Surface anatomy landmark.
Study NCT03531320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D07001-softgel capsules
Description: Active Ingredient:Gemcitabine hydrochloride
Study NCT00988403 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fructan - 7.5
Description: Subjects will consume 7.5 grams of fructan
Study NCT00988403 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fructan - 10
Description: Subjects will consume 10 grams of fructan
Study NCT00988403 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fructan - 12.5
Description: Subjects will consume 12.5 grams of fructan
Study NCT00988403 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fructan -- 5 grams
Description: Subjects will consume 5 grams fructan.
Study NCT02980055 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: collagen matrix
Description: Surgical procedure for root coverage using collagen matrix
Study NCT02980055 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: connective tissue graft
Description: Surgical procedure for root coverage using connective tissue graft
Study NCT03371082 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Gan & Lee Insulin Glargine Injection
Description: Route of administration: subcutaneous injection
Study NCT03371082 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Lantus®
Description: Route of administration: subcutaneous injection
Study NCT01319266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocodone Bitartrate extended-release tablet
Description: Hydrocodone bitartrate extended-release oral tablet will be administered at a dose of 45 mg and dosed one time on Day 1. Subjects will also be dosed with naltrexone hydrochloride to block opioid effects.
Study NCT01229631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Juice plus+
Description: Subjects in active group will be supplemented with Juice plus+ capsules (3 in the morning and 3 in the evening, for 3 months)
Study NCT01229631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo non active capsules
Description: Subjects will take non-active placebo capsules (3 in the morning and 3 in the evening, for 3 months)
Study NCT03323333 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychosocial counseling
Description: A problem-solving and psychosocial skill-building intervention.
Study NCT01813474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: tablet oral
Study NCT04478721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temocillin
Description: The intervention of experimental arm will be Intravenous administration of temocillin.
Study NCT01785797 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silicon subdural drain placement after burr hole evacuation of chronic subdural hematoma
Study NCT03037450 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Miniinvasive corneal neurotization
Description: Neurotization of a neurotrophic cornea
Study NCT02186210 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: prewarming
Description: recovery slope StO2
Study NCT04478721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meropenem
Description: The intervention of comparator arm will be intravenous administration of meropenem.
Study NCT00000412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alendronate
Study NCT00000412 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Calcitriol
Study NCT04576468 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open flap debridement
Description: Surgical intevention
Study NCT00000412 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Alendronate
Study NCT04576468 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: perforated membrane
Description: surgical intervention
Study NCT04576468 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: leucocyte - platelet rich fibrin
Description: surgical intervention
Study NCT06393621 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: KEFPEP®
Description: Twice daily (one pack before breakfast and the other before dinner)
Study NCT06393621 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Twice daily (one pack before breakfast and the other before dinner)
Study NCT01732068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptorelin
Description: Triptorelin 0.1 mg/1 ml solution daily from day 1 or 2 of the cycle onwards
Study NCT01732068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa
Description: Corifollitropin alfa 150μg (single dose) on day 2 or 3 of the cycle
Study NCT01732068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hpHMG
Description: 300IU hMG daily from day 7 following Corifollitropin alfa until the day of ovulation triggering
Study NCT01245010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water
Description: Water and education will be provided
Study NCT01245010 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: Education
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 7,5 mg/ml. 10 ml for the femoral nerve, 10 ml for the anterior division of the obturator nerve, 5 ml for the lateral femoral cutaneous nerve.
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 7,5 mg/ml. 10 ml for the anterior division of the obturator nerve, 5 ml for the lateral femoral cutaneous nerve.
Study NCT00000412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Calcitriol
Study NCT04157296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Description: The CBT intervention will consist of 12 weekly 60 minute sessions of the manualized therapy, adapted from the Coping Cat program, for the treatment of pediatric anxiety disorders.
Study NCT04157296 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Description: The CBT intervention will consist of 12 weekly 60 minute sessions of the manualized therapy, adapted from the Coping Cat program, for the treatment of pediatric anxiety disorders.
Study NCT04157296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: computerized cognitive training (CCT)
Description: CCT intervention will consist of approximately 30 minutes of CCT games prior to each CBT session, to engage cognitive control capacity prior to receipt of CBT. The CCT games will be designed to target focused attention, response inhibition, working memory and multiple simultaneous attention to constitute a general executive function training, and activate neural systems associated with executive function/cognitive control. Difficulty of the games will be titrated individually and by session to avoid boredom and progressively activate the functional systems underlying cognitive control.
Study NCT01276925 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: All nerve blockades will be performed with ultrasound guidance.
Study NCT01276925 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Ultrasound
Description: All nerve blockades will be performed with ultrasound guidance.
Study NCT01276925 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral nerve blockade
Description: All patients will receive injections around the three nerves before surgery.
Study NCT01276925 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Peripheral nerve blockade
Description: All patients will receive injections around the three nerves before surgery.
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Isotonic. 10 ml for the femoral nerve.
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: Isotonic. 10 ml for the femoral nerve.
Study NCT01276925 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total hip arthroplasty
Description: All patients undergoes total hip arthroplasty.
Study NCT01276925 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Total hip arthroplasty
Description: All patients undergoes total hip arthroplasty.
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: 5 mg/ml. 3 ml for spinal anaesthesia.
Study NCT01276925 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Bupivacaine
Description: 5 mg/ml. 3 ml for spinal anaesthesia.
Study NCT01569438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefapixant
Description: 50 or 300 mg tablets for a total daily dose of 50, 100, 150, 200, 250 or 300 mg BID, orally with food for 4 weeks
Study NCT01569438 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dose matched placebo tablets, BID, orally, with food for 4 weeks
Study NCT01207102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: Abraxane® 100 mg/m2 IV over 30 min days 1,8,15 every 28 days
Study NCT01207102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: area under curve(AUC)=2 over 15 minutes days 1,8,15 every 28 days
Study NCT00788879 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TSSC
Description: The intervention community is exposed to the media messages of the TSSC campaign. Residents of this community also receive the lay health worker visits as well as benefit from the positive built environment changes.
Study NCT03496792 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Limb occlusion + negative pressure
Description: In Visit 2, a cuff will be placed on the thigh of a leg that is sealed in an airtight pressure tank. After the cuff is inflated to 250 mmHg, the pressure in the tank will be reduced to -100mmHg for 2 minutes. The application of negative pressure creates a suction effect on the leg, and leads to an overall increase in pressure gradient across the blood vessel wall and induces vascular distension.
Study NCT03496792 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Limb occlusion + no negative pressure
Description: In Visit 2, a cuff will be placed on the thigh of a leg that is sealed in an airtight pressure tank. The cuff is inflated to 250 mmHg for 2 minutes, but the pressure in the tank is not changed.
Study NCT02461368 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Glenohumeral triamcinolone injection by anterior approach
Description: Glenohumeral steroid injection is performed under ultrasound-guidance by anterior approach. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
Study NCT02461368 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Glenohumeral triamcinolone injection by posterior approach
Description: Glenohumeral steroid injection is performed under ultrasound-guidance by posterior approach. The injection mixture was: 1 mL triamcinolone, 4 mL lidocaine, 4 mL normal saline, and 3 mL Omnipaque (Iohexol, General Electronics Healthcare).
Study NCT01073306 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational Vaccine for Dengue Virus Subtype 2
Description: Subcutaneous injection in upper arm of vaccine at dose of 10 plaque-forming units (PFU)
Study NCT01073306 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous injection of placebo
Study NCT01266174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eltoprazine
Description: Comparison of eltoprazine, dosed orally, for 8 weeks
Study NCT01266174 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match eltoprazine
Study NCT02212405 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive Transcranial Magnetic Stimulation
Description: Each participant will participate in all three arms to receive sham, 1hz and 10hz rTMS as well as PET imaging.
Study NCT02212405 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation Sham
Description: The sham coil is built in the same helmet of the active coil. The sham coil is has a circular shape and placed perpendicular to the scalp within the same helmet. This coil produces a similar sound and scalp sensation as the real coil.
Study NCT03177356 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction,implant placement,PRF
Description: Surgical extraction of mandibular molar using periotome and forceps followed by implant placement in inter-septal bone. Then a blood sample is withdrawn from patient and placed in the centrifuge. Then Platelet-Rich fibrin is placed in the extraction socket as space filling material
Study NCT03177356 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exctraction,Implant placement,Bone graft
Description: Surgical extraction of mandibular molar using extraction forceps and periotome followed by implant placement in interseptal bone. De-proteinized bovine bone graft material is placed as space filling material
Study NCT00982410 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive-behavioral treatment
Description: cognitive-behavioral treatment (CBT) interventions to manage pain and decrease substance use abuse/misuse
Study NCT00982410 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: educational supportive group
Description: A control condition providing social support and education about pain and/or drug use.
Study NCT04117308 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Classic information
Description: The team delivers to each patient a unique and standardized information brochure including a definition of fetal active movements, and the need to consult if the patient perceives less the movements of her fetus.
Study NCT04117308 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Information by detailed brochure on the fetal active movements account
Description: Delayed single and standardized explanatory card on fetal movements (definition, interests of their follow-up, technique of movements on fetuses, table to fill during the follow-up noting the number of active movements physical feelings at 3 times of the day, managing the decrease in the number of active fetal movements).
Study NCT00710138 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)
Description: 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma), as a single intramuscular injection
Study NCT00710138 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)
Description: 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma), as a single intramuscular injection
Study NCT00534131 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard abdominal approach for rectal excision
Description: Standard abdominal approach for rectal excision
Study NCT00534131 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: APPEAR Procedure
Description: Perineal incision to reach the distal rectum
Study NCT03492723 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract
Description: NR
Study NCT03492723 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Aged Garlic Extract
Description: NR
Study NCT03645395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-3724
Description: Experimental treatment with MT-3724 in combination with LEN therapy.
Study NCT00534131 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Proctectomy
Description: standard rectal excision which does not preserve the anal canal
Study NCT04501510 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasonographic examination validation and testing
Description: X-ray imaging as well as the ultrasonographic examination of the fracture and healing process in children will be performed. The validation of an usg will be done.
Study NCT04159480 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental - Cogito Companion
Description: Cogito Companion
Study NCT04159480 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Use of MyCAP
Study NCT01032655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: susceptibility test guided sequential therapy
Description: susceptibility test driven sequential therapy D1- D7 Nexium ,40mg, bid Amolin, 1gm bid D8-14 Nexium ,, 40mg, bid Flagyl, 500mg, bid~plus either one of the following~1. Klaricid, 500 mg, bid~2. Cravit, 250 mg, bid~3. Tetracycline, 500 mg, bid
Study NCT04489043 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and healthy lifestyle recommendations
Description: In the present study, renal transplant patients with proven prediabetes will do a planned exercise programme to test the impact of this treatment on the reversibility of prediabetes. Thus, the persistance of recurrency of prediabetes assessed by an Oral Glucose Tolerant Test (OGTT) at intermediate time points (3, 6 and 9 months) will be checked in order to increase the frequency and duration of aerobic exercise and eventually to add anaerobic/resistance training.
Study NCT03733405 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Postpartum Visit at 6 Weeks
Description: The patient will be scheduled for a routine postpartum visit at the standard time interval. Each postpartum visit will consist of the standard interview and physical examination. The purpose of this visit is for routine postpartum care. If she has a medical complication during delivery, she may be recommended to schedule an additional earlier visit.
Study NCT03733405 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Postpartum Visit at 2 Weeks
Description: The patient will be scheduled for an earlier postpartum visit in addition to the standard time interval. Each postpartum visit will consist of the standard interview and physical examination. The purpose of this visit is for routine postpartum care. If she has a medical complication during delivery, she may be recommended to schedule an additional earlier visit.
Study NCT00404365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: counseling intervention
Study NCT00404365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: screening questionnaire administration
Study NCT00404365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: study of socioeconomic and demographic variables
Study NCT00404365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: psychosocial assessment and care
Study NCT01656889 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HP-802-247
Description: HP802-247 (fibrinogen solution \& thrombin solution containing living, irradiated, growth arrested keratinocytes and fibroblasts) 260 µL (130 µL, one spray, of each solution) containing 0.5 x 106 cells per mL every 14 days.
Study NCT04360525 — intervention group
Intervention type: OTHER
Intervention: Reasons
Description: Causes of sigmoid volvulus
Study NCT03797521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SXC-2023
Description: SXC-2023 oral capsules
Study NCT03797521 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo oral capsules
Study NCT04450602 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: ALRV5XR
Description: ALRV5XR oral supplement. Dose/Route/Schedule: 1 capsule/oral twice daily. Take one capsule in the morning and one capsule in the evening. Take 30-60 minutes before food. If stomach upset occurs, subjects will be instructed to take the capsule at the beginning of a meal.~There should be no deviation from the daily nutriment regimen (although in the event a capsule or day is missed, subject should continue with regimen the following day.)